Analysis

Analysis

Two Final Events Hold the Key for Sellas Life Sciences as the Stock Races Ahead of Its Fundamentals

AI & Quantum Computing

With a Memory Advantage and Revenue Milestones, AMD Heads into July’s AI Event Under the Microscope

Analysis

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

Home Category Analysis

Analysis

Ams Osram Sells Sensors to Infineon for €570m, but the Debt Disconnect Remains Stark

by SiterGedge

The completion of the non-optical sensor unit sale to Infineon on July 1, 2026 sent Ams Osram shares surging 7.96%...

Take-Two’s Digital Pivot and Pipeline Bet Bolster GTA VI Hype as Insider Sales Flash a Warning

by Kennethcix

Take-Two Interactive has kicked off pre-orders for Grand Theft Auto VI since June 25, and the stock is already within...

Micron Faces a Twin Assault: A Short Seller’s Warning and a Cartel Lawsuit Test the AI Rally

The euphoria over memory chips has drawn two distinctly unwelcome guests to the party. Michael Burry, the investor famous for...

German Workers Losing Faith in Retirement as Coalition Tightens Sick-Leave Rules

by Kennethcix

More than two in five employees do not believe they can remain in their jobs until they reach retirement age,...

Bayer’s Rally Faces a New Test: Antidumping Bid vs. Overbought Charts After Court Win

Just five days after a landmark Supreme Court victory, Bayer has opened a second front in its glyphosate saga —...

Outlook Therapeutics Braces for a Five-Day Gauntlet: Shareholder Vote on Survival Followed by FDA Decision on ONS-5010

July is shaping up as a binary-riddled month for the small-cap biopharma. Two weeks after shareholders cast decisive ballots on...

Mercedes-Benz Stock Mounts Comeback as Labor Dispute Escalates Over Soured Bonus Payments

by Kennethcix

The Stuttgart automaker finds itself caught between a nascent share-price recovery and a rapidly escalating confrontation with its workforce. While...

Intuit’s Valuation Discount Is Tempting — But Lawsuits and a DIY Price War Keep Buyers at Bay

Bargain hunters eyeing Intuit's beaten-down shares are facing a dilemma that few valuation models can resolve. The stock closed at...

ImmunityBio’s 369% Surge Meets 13% Short Interest — A Collision Course in Biotech

by Jackson Burston

ImmunityBio has become a battleground stock where two opposing forces are digging in. Retail traders have piled into the biotech...

TUI Juggles Record Complaints and Airport Logjams as Hotel Expansion Bid Seeks to Revive Stock

by SiterGedge